Royalty Pharma plc

RPRX Healthcare
$38.53 +$0.14 (0.36%)
Market Cap: $22.24 B
Gurus Holding
4
Popularity Rank
#2168
% of Shares Held
0.96%
Net Activity (Q3 2025)
+$5.11 M

Guru Ownership Over Time

Guru Analysis for Royalty Pharma plc (RPRX)

Royalty Pharma plc (RPRX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $213.07 M.

Top institutional holders include Pat Dorsey and Cliff Asness.

Notably, Pat Dorsey has expressed high conviction in this stock, allocating 7.45% of their equity portfolio to it.

Institutional sentiment is currently Bullish. This is evidenced by a $5.11 M net inflow during the quarter.

Recent activity highlights Pat Dorsey who opened a new position.

Portfolio Manager % of portfolio Activity Shares Value Peroid
7.45% New Buy 2,350,449 $82.92 M Q3 2025
0.04% Add 13.0% 1,961,086 $69.19 M Q3 2025
0.05% Add 34.4% 863,835 $30.48 M Q3 2025
0.15% Add 0.3% 354,685 $12.51 M Q3 2025

Key Holders

Top 5 by Value

$82.92 M
$69.19 M
$30.48 M
$12.51 M

Top 5 by Conviction

Recent Activity Breakdown(Q3 2025)

+$98.7 M
Total Buy Value
New Buys: 1
Additions: 3
-$93.59 M
Total Sell Value
Reductions: 0
Sold Out: 1

Guru Consensus (Q3 2025)

Based on recent guru activity
Net Sellers
1
Net Buyers
4

FAQs for Royalty Pharma plc (RPRX)

Top Guru holders include Pat Dorsey ($82.92 M), Cliff Asness ($69.19 M), Paul Tudor Jones ($30.48 M). Collectively, tracked Gurus hold 5.53 M shares.

Based on recent 13F filings, the sentiment is **Positive (Net Buy)**. There was a net inflow of $5.11 M, with 4 Gurus buying and 1 Gurus selling.

In the recent quarter, 0 Gurus reduced their positions, and 1 Gurus sold out of RPRX completely. Total sell value was $93.59 M.

Yes, 1 Gurus opened new positions in RPRX, and 3 added to their existing holdings. Total buy value was $98.7 M.